Genes, Drugs, and Diseases for a Pharmacogenetics Knowledge Base Diane E. Oliver, MD, PhD Stanford University SOFG – Nov. 19, 2002.
Pharmacogenetics: Clinical Application of Population and Individual Preemptive Genetic Data David F. Kisor, BS, PharmDDavid R. Bright, BS, PharmD Professor.
Trends Biomedical In silico. “Omics” a variety of new technologies help explain both normal and abnormal cell pathways, networks, and processes simultaneous.
Pharmacogenetics Clinical Decision Support System
